Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys)
- 2 November 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal of Pharmacology
- Vol. 505 (1-3) , 169-175
- https://doi.org/10.1016/j.ejphar.2004.10.007
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPDThorax, 2003
- New Concepts in Chronic Obstructive Pulmonary DiseaseAnnual Review of Medicine, 2003
- Exhaled markers of inflammationCurrent Opinion in Allergy and Clinical Immunology, 2001
- Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2000
- Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax, 2000
- The global burden of disease, 1990–2020Nature Medicine, 1998
- Statistics Notes: Measurement errorBMJ, 1996
- Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary diseaseFree Radical Biology & Medicine, 1996
- Effectiveness of carbocysteine lysine salt monohydrate on models of airway inflammation and hyperresponsivenessPharmacological Research, 1995
- The natural history of chronic airflow obstruction.BMJ, 1977